FDA approves MSD’s Keytruda combinations for MIBC

The US Food and Drug Administration (FDA) has approved two of Merck & Co's (MSD) Keytruda (pembrolizumab) and Keytruda Qlex ...

Quantum Computers Identify Nuclear Fusion Fuel Chemistry in Major First

A major barrier to harnessing energy via nuclear fusion is the fuel source. Most proposed fusion reactors (the donut-shaped ...
MPR

Subcutaneous Sarclisa Escena Receives FDA Nod for Multiple Myeloma

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
The Manila Times

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector ...
Pharmaceutical Technology

EC approves AbbVie’s Tepkinly combination for follicular lymphoma

The EC has granted marketing authorisation for AbbVie’s Tepkinly in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma.

Tampa Bay Rays’ 2026 All-Stars A Combination Of Pitching And Power

Junior Caminero, Drew Rasmussen, Yandy Diaz and Bryan Baker, who will gladly scrap his typical mid-season routine, will ...
Rutland Herald

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory ...

Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...